Comparison of the efficacy of fixed-dose enoxaparin and adjusted-dose unfractionated heparin in patients with cerebral venous thrombosis

Cerebral venous thrombosis (CVT) is a potentially fatal disease [1]. The incidence of CVT in Europe and America was estimated to be 3 to 4 patients per million population while the incidence in the Asian population was not well documented [2]. Although there are various precipitating factors that contribute to CVT, different genetic backgrounds lead to a lower incidence of thrombophilia-related CVT in the Asian population than in the Western population [3].

Source: Clinical Neurology and Neurosurgery - May 10, 2017 Category: Neurosurgery Authors: Pat Korathanakhun, Chusana Petpichetchian, Wongchan Petpichetchian, Pornchai Sathirapanya Tags: Full Length Article Source Type: research